Samsung Biologics stock price & AI analysis
207940한국어EnglishBiologics contract manufacturing (CDMO) · Korea (KRX) · Updated 2026-09-06 00:16 KST
Price
₩1,447,000
vs prev. close -2.03%
52-week range
₩1,228,000 ~ ₩1,987,000
29% of the 52-week range
AI score
-5.6
Tilt: Neutral
Market cap
₩67.0T
Korea (KRX) · 207940
Valuation & fundamentals
| Market cap | ₩67.0T |
| P/E | — |
| Forward P/E | 29.5 |
| Beta | 0.21 |
| Dividend yield | — |
| Sector | Healthcare |
AI score factors — why -5.6
| 1 | моментум20 -4.4% |
| 2 | в диапазоне 51% |
| 3 | 뉴스·소셜 +0.10 (29건) |
Factor contributions, gap-statistics backtests and institutional/insider flows open after a free sign-up.
See the full analysis free
Narratives around Samsung Biologics right now
Market narratives are generated in Korean for now — the latest ones are on the
Korean page. Ask the AI analyst in English inside the app.
Narrative trends and volatility alerts are in the app.
Start free
FAQ
- What is the Samsung Biologics stock price right now?
- ₩1,447,000 as of 2026-09-06 00:16 KST, -2.03% vs previous close. The 52-week range is ₩1,228,000 to ₩1,987,000; the current price sits at 29% of the 52-week range.
- How is Daepak's Samsung Biologics AI score computed?
- It combines news and social sentiment with price momentum, volatility and gap statistics into a -100 to +100 reading. It summarises the current state of the market, it is not a price forecast. Factor contributions and the historical hit rate are in the dashboard.
- Where can I follow Samsung Biologics news?
- Daepak collects Korean and global news and social data and summarises them into per-ticker narratives. Real-time alerts and full narrative history are in the app.
Korean stocks, US stocks and crypto on one screen
Daepak AI scores news, social and price data in real time. Free to join, no card required.
Start free AI analysis →This page is for information only and is not investment advice. You are responsible for your own decisions.
Daepak